IL95663A0 - Stabilized aqueous formulations of small peptides - Google Patents

Stabilized aqueous formulations of small peptides

Info

Publication number
IL95663A0
IL95663A0 IL95663A IL9566390A IL95663A0 IL 95663 A0 IL95663 A0 IL 95663A0 IL 95663 A IL95663 A IL 95663A IL 9566390 A IL9566390 A IL 9566390A IL 95663 A0 IL95663 A0 IL 95663A0
Authority
IL
Israel
Prior art keywords
small peptides
aqueous formulations
stabilized aqueous
stabilized
formulations
Prior art date
Application number
IL95663A
Other languages
English (en)
Original Assignee
Immunobiology Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Res Inst Inc filed Critical Immunobiology Res Inst Inc
Publication of IL95663A0 publication Critical patent/IL95663A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL95663A 1989-09-28 1990-09-12 Stabilized aqueous formulations of small peptides IL95663A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41384189A 1989-09-28 1989-09-28

Publications (1)

Publication Number Publication Date
IL95663A0 true IL95663A0 (en) 1991-06-30

Family

ID=23638883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95663A IL95663A0 (en) 1989-09-28 1990-09-12 Stabilized aqueous formulations of small peptides

Country Status (14)

Country Link
EP (1) EP0420649A3 (fr)
JP (1) JPH04502017A (fr)
AU (1) AU6446790A (fr)
BR (1) BR9006934A (fr)
CA (1) CA2026149A1 (fr)
DD (1) DD298053A5 (fr)
HU (1) HUT59013A (fr)
IE (1) IE903475A1 (fr)
IL (1) IL95663A0 (fr)
IT (1) IT1240314B (fr)
NZ (1) NZ235324A (fr)
PT (1) PT95451A (fr)
WO (1) WO1991004743A1 (fr)
ZA (1) ZA907492B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
JP3537440B2 (ja) * 1993-12-17 2004-06-14 持田製薬株式会社 可溶性トロンボモジュリンを長期保存安定化させる方法
CA2192725C (fr) 1995-12-28 2004-04-20 Kenji Tsujihara Derives de la camptothecine
JP5485489B2 (ja) * 2000-08-11 2014-05-07 中外製薬株式会社 抗体含有安定化製剤
US7425618B2 (en) 2002-06-14 2008-09-16 Medimmune, Inc. Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
PL2107069T3 (pl) 2003-08-05 2013-06-28 Novo Nordisk As Nowe pochodne insuliny
DE102004011663B4 (de) 2004-03-10 2006-04-27 Bioceuticals Arzneimittel Ag Erythropoietin-Flüssigformulierung
DK1969004T3 (da) 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
WO2008152106A1 (fr) 2007-06-13 2008-12-18 Novo Nordisk A/S Formulation pharmaceutique contenant un dérivé d'insuline
CN109010254A (zh) 2008-08-15 2018-12-18 硬木药品公司 适合口服给药的鸟苷酸环化酶-c受体激动剂多肽的稳定的固体制剂
AU2009309623B9 (en) 2008-10-30 2014-10-02 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
CA2742659C (fr) * 2008-11-04 2016-09-27 Aska Pharmaceutical Co., Ltd. Composition aqueuse contenant de l'hormone folliculostimulante
JP2013501071A (ja) 2009-08-06 2013-01-10 アイロンウッド ファーマシューティカルズ， インコーポレイテッド リナクロチドを含む処方物
TWI609698B (zh) * 2010-01-20 2018-01-01 Chugai Pharmaceutical Co Ltd 穩定化的含抗體溶液製劑
EP2536742B1 (fr) 2010-02-17 2017-07-19 Ironwood Pharmaceuticals, Inc. Traitements de troubles gastro-intestinaux
ES2919136T3 (es) 2010-08-11 2022-07-22 Ironwood Pharmaceuticals Inc Formulaciones estables de linaclotida
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
KR101673654B1 (ko) 2011-04-20 2016-11-07 산도즈 아게 융합 단백질 TNFR:Fc의 안정한 제약 액체 제제
HUE032237T2 (en) 2011-08-17 2017-09-28 Ironwood Pharmaceuticals Inc Treatment of gastrointestinal disorders
US10493151B2 (en) 2011-10-18 2019-12-03 Coherus Biosciences, Inc. Etanercept formulations stabilized with sodium chloride
WO2013059410A1 (fr) 2011-10-18 2013-04-25 Coherus Biosciences, Inc. Préparations d'étanercept stabilisées avec du xylitol
EA031324B1 (ru) 2012-09-11 2018-12-28 Кохерус Байосайенсис, Инк. Правильно свернутый этанерцепт с высокой чистотой и высоким уровнем выхода
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
CN105012232B (zh) * 2015-08-14 2017-09-05 北京世桥生物制药有限公司 一种胸腺五肽注射液及其制作方法
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2023017537A1 (fr) 2021-08-12 2023-02-16 Celagenex Research (India) Pvt. Ltd. Composition peptidique orale perméable au tractus gastro-intestinal à base d'huile algale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
JPS57169425A (en) * 1981-04-10 1982-10-19 Eisai Co Ltd Composition and method for preventing adsorption of secretin
EP0082481B2 (fr) * 1981-12-23 1990-09-12 Schering Corporation Compositions stabilisées d'interféron alpha et leur préparation
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.
US4749690A (en) * 1986-01-27 1988-06-07 Ortho Pharmaceutical Corporation Treatment of allergy with thymopentin
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
HUT59013A (en) 1992-04-28
JPH04502017A (ja) 1992-04-09
EP0420649A3 (en) 1991-07-31
AU6446790A (en) 1991-04-28
IT9019421A0 (it) 1990-02-20
HU907939D0 (en) 1991-08-28
IT1240314B (it) 1993-12-07
BR9006934A (pt) 1991-10-22
IT9019421A1 (it) 1991-03-29
CA2026149A1 (fr) 1991-03-29
PT95451A (pt) 1991-05-22
WO1991004743A1 (fr) 1991-04-18
DD298053A5 (de) 1992-02-06
ZA907492B (en) 1991-10-30
EP0420649A2 (fr) 1991-04-03
NZ235324A (en) 1992-07-28
IE903475A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
HU907939D0 (en) Stabilized aqueous formulations of small peptides
HUP0000589A3 (en) Aqueous formulations of peptides
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
EP0390930A4 (en) Stable aqueous preparation of active vitamin d 3?
GB8908250D0 (en) Formulations
IL96306A0 (en) Preparation of deoxyfluoronucleosides
SG47072A1 (en) Water-containing external preparations
ZA902519B (en) Pharmaceutical formulations
AP9000174A0 (en) Antiparasitical formulations
EP0450100A4 (en) Physiologically active peptide
GB8619182D0 (en) Peptides & derivatives
GB8916391D0 (en) Preparation of polyacetals
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GB8918394D0 (en) Preparation of polyhemiacetals
IL89362A0 (en) Preparation of tetrabromotetralin
CS275222B2 (en) Analogues of deamino-vasopressin
GB8808440D0 (en) Preparation of peptide derivatives
IE892415L (en) Preparation of polyhydroxysilazanes
IE893752L (en) Preparation of n-acyl-aminomethyl-phosphonates
IE894144L (en) Preparation of deglucoteicoplanin
IE892537L (en) Preparation of trifluoroethanol.
NO911988L (no) Stabiliserte vandige formuleringer av smaa peptider.
IE890708L (en) Peptide equivalents of non-peptides
GB8619181D0 (en) Peptides & derivatives
GB8828413D0 (en) Ws7528 substance & preparation thereof